days. Three of the patients had signs suggesting CNS dysfunction. Electromyographic studies suggested a neuromuscular junction (NMJ) defect of the postsynaptic type, but the exact mechanism of the dysfunction was not determined. 5o We describe the pathophysiological changes in a patient who presented with a subacute progressive neuromuscular syndrome without marked symptoms of acute toxicity after multiple OP insecticide sprayings. The defect in this neuromuscular syndrome occurred at the endplate-receptor sites, is similar to the intermediate syndrome previously reported,10 and differs from the acute and delayed syndromes. l These results are important in the diagnosis and management of patients exposed to organophosphates. A preliminary report of this study has been published in abstract form. " Case report A 51 year old man was admitted to the hospital 5 days after the onset of diplopia, light headedness and a staggering gait. The patient developed these symptoms 18 hours after the fifth weekly exposure to a liquid spray insecticide containing an organophosphate compound, phosmet, (phosphorodiothioic acid S-[(1,3-dihydro-1 ,3-dioxo-2H-isoindol-2-yl) methyl] 0,0-dimethylester). He described his face and hands becoming wet from the insecticide and he did not bathe until the following morning. Over the next few days, he noted progressive unsteadiness of gait, dysphagia, change in voice tone and excessive diaphoresis. Five days after exposure, he noted jaw weakness and droopy eyelids.
The patient's general examination was normal. Profuse oral secretions, bilateral ptosis, and marked facial diaphoresis were noted. He was alert, mentation was normal, and speech was dysarthric. Extraocular movements were limited in all directions with the exception of downgaze. Pupils were 3 mm and reactive to light. There was moderate symmetrical weakness of facial, jaw, tongue and neck muscles. There was mild weakness of distal muscles and marked weakness of proximal muscles, especially antigravity muscles that fatigued. The tendon jerks were brisk throughout. Bilateral Babinski responses were present. Sensory examination was normal.
The patient was admitted with the presumed diagnosis of acute OP poisoning. Atropine (2 mg) and pralidoxime chloride (2-PAM, 1 gm) infusions were started. Within several minutes of 2-PAM infusion, the patient had increased systemic and ventilatory weakness requiring intubation. After the patient was stabilised on a ventilator, 3 additional doses of 2-PAM were given without side effects over the next 24 hours. Atropine (1 0 mg initially and thereafter 0-5 mg) was continued 4 times daily for 6 days. Paralysis was maximum on day 9. At this time, he was observed to have visual hallucinations, disorientation, and myoclonic jerks of his extremities. These signs persisted for approximately 10 days during which time the EEC showed diffuse slow wave activity. The patient remained unchanged for the following 18 days, and supportive care continued. By day 28, there was improvement in strength of neck flexion, shoulder and antigravity muscles. By day 44, he no longer required mechanical ventilation or tube feedings. Babinski responses were absent. Examination on day 64 (time of the muscle biopsy) showed that he had mild fatiguable proximal and antigravity muscle weakness in the upper and lower limbs. Facial and oropharyngeal movements were near normal. There was mild subjective diplopia on extreme lateral gaze. Neuromuscular examination was normal by 5 months.
Laboratory studies revealed normal routine blood and urine studies, creatine kinase, EKG and chest radiographs. MRI of the brain was normal. CSF was normal except for a total protein of 75 mg%. On admission red blood cell cholinesterase level was within normal limits (6110 U/L); and follow up levels on days 16 and 23 were 5420 and 4180 respectively and at 10 months (5114 U/L) remained normal (normal range 6666-3590). Studies to rule out other causes of neuromuscular disease were normal. ANA and acetylcholine receptor antibody titres were negative.
Methods
Nerve conduction and repetitive stimulationneuromuscular studies were performed in peripheral nerves of upper and lower extremities using established techniques.'2 53 Recordings were performed in the intensive care unit and care was taken to keep the patient warm (rectal temperature of 37°C) during the procedure. Recordings were obtained at 9 to 95 days after exposure to phosmet.
Repetitive stimulation was performed at rates of 2, 5, 10, 20, and 50 Hz for 9 responses in the median and peroneal nerves. Recordings of the median nerve were made before and after 10 mg of intravenous edrophonium at days 11 to 47. Recordings were made 5 to 40 minutes after 1-5 mg of intramuscular neostigmine on day 12. Measurements of the motor amplitudes were peak-to-peak and percentage change (decrement) was calculated for the fourth and ninth responses compared with the initial one.
Concentric needle and single fibre (SF EMG) electromyography and fibre densities were performed in the extensor digitorum communis and first dorsal interosseus muscles using established techniques. 14 SF EMG recordings were obtained when the patient was improving and able to cooperate, 3-4 months after exposure.
A diagnostic intercostal muscle biopsy was obtained 2 months after exposure because of persistent muscle weakness with informed consent by the patient. Muscle was removed from the right sixth intercostal space in the anterior axillary line using standardised aneasthesia and surgical technique. The muscle was immediately placed in oxygenated KrebsRinger solution and prepared for intracellular recordings and ultrastructure as previously described. ' Three months after exposure when the patient had mild proximal muscle weakness and fatiguability, no decremental responses were observed. However, SF EMG revealed increased variability in the interpotential intervals (jitter) in all 20 potential pairs examined. figure 2 ). Some endplates showed subsynaptic vesiculation and phagocytic lysosomal activity suggesting degeneration. At higher magnification some of the secondary synaptic clefts were widened and filled with debris and junctional folds were simplified suggesting endplate damage.
Discussion
The patient described in this report had a subacute progressive neuromuscular symdrome associated with CNS dysfunction following the fifth weekly spraying with phosmet, an OP insecticide. Paralysis became maximum by 9 days, continued for 30 days, but some weakness persisted for 4 months. CNS signs of visual hallucinations, disorientation and myoclonic jerks occurred at the peak of the toxicity and most likely reflected central cholinergic dysfunction. Edrophonium is recommended as a test in OP toxicity to document the acute cholinergic block. The acute syndrome may benefit from therapy with pralidoxime chloride, an AChE reactivator that may have varied actions,'8 but it should not be used in the subacute syndrome with postsynaptic dysfunction, since it may increase the neuromuscular block and weakness.
The endplate physiological findings in this patient with subacute neuromuscular weakness are similar to those reported in myasthenia gravis that have shown loss of functional postsynaptic ACh receptors.'5 9 The mechanism of receptor loss in subacute phosmet toxicity is unknown but is likely to result from endplate degeneration as shown on the ultrastructural studies. The physiological findings of mildly prolonged distal motor latency and reduced mepp frequency and the pathological finding of endplate damage suggest that nerve terminals may be affected by OP toxicity. Experimental studies with chronic AChE inhibitor toxicity in rats have shown similar physiological and morphological changes of the neuromuscular junctions.202' Postsynaptic dysfunction was greater and persisted longer than presynaptic changes, was prevented by chronic nerve section and was therefore possibly due to the prolonged increased activity of synaptic ACh. Prolonged action of ACh at the NMJ has been reported to produce a myopathy that is mediated by calcium activation of a protease and requires intact ACh receptors.22 A myopathy was not observed in our patient and this may reflect the endplate degeneration with loss of receptors. Prolonged action of synaptic ACh accounts for the acute OP syndrome, and it is possible that it may induce the subacute neuromuscular syndrome by prolonged receptor desensitisation and influx of calcium that damages the NMJ. The endplate damage may be enhanced also by the direct effects of AChE inhibitors that act as AChR agonists and channel blockers.23 It is possible that similar changes may occur at CNS cholinergic junctions. In addition, unpublished data from our laboratory suggest that organophosphates cause release of excitatory and inhibitory transmitters in the CNS. 24 Our patient was exposed to phosmet, an insecticide recommended for the control of fruit tree pests.25 It is less toxic as an AChE inhibitor than other insecticides such as parathion.26 Phosmet has very low water solubility and is lipid soluble.26 It is possible that repeated weekly exposure to a lipid soluble OP, like phosmet, spray by inhalation and skin contact resulted in the subacute progressive neuromuscular and CNS syndrome in our patient. There are no other reports of subacute toxicity due to phosmet but fenthion, which also has high lipid solubility, produced 4 of the 10 reported cases of the intermediate syndrome.'o Proposed mechanisms by which some of the OP may produce subacute effects range from higher lipid solubility to delayed conversion to a more active metabolite.227 Although it is possible that the insecticide which the patient used contained a toxic product of phosmet, there are no reports of other toxic substances in the compound. 25 
